Product Information
CYCLOBENZAPRINE 7.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.2600 per EA under NDC 72888001301. Its NADAC has been published 213 times since Jun 1, 2022.
Strength
7.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888001301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208170On Market Since
5/31/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 78.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2600 per EA |
|---|---|
| All-time high | $1.2190 (Jul 13, 2022) |
| All-time low | $0.2600 (Jun 17, 2026) |
| 52-week high | $0.3669 |
| 52-week low | $0.2600 |
| Median price | $0.3528 |
| Average price | $0.4404 |
| Largest weekly change | -68.4% (Oct 19, 2022) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 7.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.2600 per EA (NDC 72888001301), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has declined 78.7%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 7.5 MG TABLET?
Since Jun 1, 2022, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has ranged from a low of $0.2600 (Jun 17, 2026) to a high of $1.2190 (Jul 13, 2022), with a median of $0.3528 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 7.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 7.5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 7.5 MG TABLET?
CYCLOBENZAPRINE 7.5 MG TABLET (NDC 72888001301) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification